|
|
Volumn 5, Issue 4, 2004, Pages 345-350
|
|
Approval times and the safety of new pharmaceuticals
a
|
|
Author keywords
Adverse drug reactions; Approval times; JEL classification: L15, I10; Pharmaceutical markets
|
|
Indexed keywords
ALLOPURINOL;
ALPRAZOLAM;
ATENOLOL;
AZAPROPAZONE;
BUSPIRONE;
CIMETIDINE;
CLOMIPRAMINE;
DIAZEPAM;
DICLOFENAC;
ESTRADIOL;
ETACRYNIC ACID;
FUROSEMIDE;
INDOMETACIN;
LOFEPRAMINE;
MAPROTILINE;
MIANSERIN;
NAPROXEN;
OXAZEPAM;
PINDOLOL;
PIROXICAM;
PROPRANOLOL;
PROTRIPTYLINE;
SUCRALFATE;
SULINDAC;
TIMOLOL;
DRUG;
ARTICLE;
CONSUMER;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
EMPIRICISM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MATHEMATICAL MODEL;
PRIORITY JOURNAL;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
DRUG MONITORING;
METHODOLOGY;
POSTMARKETING SURVEILLANCE;
SAFETY;
STANDARD;
STATISTICAL MODEL;
STATISTICS;
SWEDEN;
TIME;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MONITORING;
HUMANS;
MODELS, STATISTICAL;
PHARMACEUTICAL PREPARATIONS;
PRODUCT SURVEILLANCE, POSTMARKETING;
SAFETY;
SWEDEN;
TIME FACTORS;
|
|
EID: 15944368105
PISSN: 16187598
EISSN: None
Source Type: Journal
DOI: 10.1007/s10198-004-0247-0 Document Type: Article |
|
Times cited : (2)
|
|
References (10)
|
